Tag: Alterity Therapeutics

Browse exclusive Tags!

Alterity Therapeutics to Host Investor Webcast on Recent Clinical Progress and Efficacy Data of ATH434 in Neurodegenerative Diseases, Australia

Discover the latest clinical progress and efficacy data of ATH434 in neurodegenerative diseases with Alterity Therapeutics' CEO in an upcoming investor webcast. Register now for valuable insights!

Alterity Therapeutics Receives A$4.74M Cash Refund for Research and Development, Advancing Clinical Trials for ATH434, Australia

Alterity Therapeutics receives A$4.74M cash refund for research, further advancing neurodegenerative disease treatments.

Popular

Alterity Therapeutics to Host Investor Webcast on Recent Clinical Progress and Efficacy Data of ATH434 in Neurodegenerative Diseases, Australia

Discover the latest clinical progress and efficacy data of ATH434 in neurodegenerative diseases with Alterity Therapeutics' CEO in an upcoming investor webcast. Register now for valuable insights!

Subscribe

spot_imgspot_img